5 unchanged sentences
The following graph shows the value of an investment of $100.00 made on December 31, 2018—the last trading day of 2018—in each of Pacira BioSciences, Inc.
−Removed: (PCRX), the Nasdaq Composite Index (^IXIC), the Nasdaq Biotechnology Index (^NBI) and the S&P Pharmaceuticals Select Index (^SPSIPH).
+Added: (PCRX), the Nasdaq Composite Index (^IXIC), the Nasdaq Biotechnology Index (^NBI) and the S&P Pharmaceuticals Select Index (^SPSIPH).
The three indices included are for comparative purposes only and do not necessarily reflect management’s opinion that such indices are an appropriate measure of the relative performance of our common stock.
8 unchanged sentences
(PCRX) $ 100.00 $ 105.30 $ 139.10 $ 139.87 $ 89.75 $ 70.39
−Removed: Nasdaq Composite Index (^IXIC) $ 100.00 $ 96.12 $ 129.97 $ 186.69 $ 226.63 $ 151.61
−Removed: Nasdaq Biotechnology Index (^NBI) $ 100.00 $ 90.68 $ 112.81 $ 141.78 $ 140.88 $ 125.52
−Removed: S&P Pharmaceuticals Select Index (^SPSIPH) $ 100.00 $ 84.29 $ 105.16 $ 119.45 $ 106.02 $ 94.15
+Added: Nasdaq Composite Index (^IXIC) $ 100.00 $ 135.23 $ 194.24 $ 235.78 $ 157.74 $ 205.57
+Added: Nasdaq Biotechnology Index (^NBI) $ 100.00 $ 124.41 $ 156.36 $ 155.37 $ 138.42 $ 127.49
+Added: S&P Pharmaceuticals Select Index (^SPSIPH) $ 100.00 $ 124.75 $ 141.71 $ 125.78 $ 111.70 $ 100.63
Dividend Policy
4 unchanged sentences
| 2023 Form 10-K | Page 72
−Removed: Tab le of Contents
+Added: Table of Content s
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.